24 Participants Needed

Cycling and Virtual Reality for Multiple Sclerosis

(PACE-MS Trial)

CW
Overseen ByCarly Wender, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

To compare the effects of cycling exercise with different types of virtual reality on processing/thinking speed in persons with multiple sclerosis (MS).

Will I have to stop taking my current medications?

The trial requires that you do not use medications that may impact cognition, such as steroids or benzodiazepines. If you are taking these, you may need to stop before participating.

What data supports the effectiveness of the treatment PACE-MS for multiple sclerosis?

Research suggests that both cycling and virtual reality (VR) exercises can improve physical and cognitive abilities in people with multiple sclerosis (MS). VR-based exercises, in particular, have shown to enhance motivation and therapy outcomes, potentially making them more effective than conventional exercises.12345

Is cycling and virtual reality safe for people with multiple sclerosis?

In a study where people with multiple sclerosis participated in a physical activity expedition, some experienced minor medical events, but those with mild disability and no other health issues had no problems. This suggests that physical activity, like cycling, can be safe for some people with MS, but individual health conditions should be considered.678910

How is the PACE-MS treatment different from other treatments for multiple sclerosis?

The PACE-MS treatment is unique because it combines cycling with virtual reality (VR) to enhance physical and cognitive abilities in people with multiple sclerosis. This approach leverages VR to create an engaging and immersive environment, which has been shown to improve outcomes more effectively than conventional exercise alone.24101112

Research Team

CW

Carly Wender, PhD

Principal Investigator

Kessler Foundation

Eligibility Criteria

This trial is for English-speaking individuals with a confirmed MS diagnosis by a neurologist, who have been free of relapses and steroids for at least 30 days, and report moderate mobility disability. It excludes those with other neurological disorders or uncontrolled psychiatric conditions, contraindications to exercise, cognition-impacting medications use (like steroids), current pregnancy, severe cognitive impairment, high motion sickness likelihood or regular cyclists.

Inclusion Criteria

I have been diagnosed with MS by a neurologist.
I haven't had a relapse or taken steroids in the last 30 days.
I have some difficulty moving around on my own.

Exclusion Criteria

Have contraindications to exercise, based on the Physical Activity Readiness Questionnaire (PAR-Q)
I am taking medication that could affect my thinking or memory.
Currently pregnant
See 4 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants complete three cycling conditions: cycling alone, cycling with cognitively stimulating VR, and cycling with visually stimulating VR, one per week.

3 weeks
3 visits (in-person)

Follow-up

Participants are monitored for processing speed improvements after each cycling session.

1 week

Treatment Details

Interventions

  • PACE-MS
Trial Overview The PACE-MS trial aims to compare the effects on processing/thinking speed in people with MS when they participate in cycling exercises combined with different types of virtual reality experiences.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Cycling with Visually Stimulating VRExperimental Treatment1 Intervention
Cycling with virtual reality where I only have to look at the environment while I cycle.
Group II: Cycling with Cognitively Stimulating VRExperimental Treatment1 Intervention
Cycling with virtual reality where I have to complete a thinking task while cycling in the virtual environment.
Group III: Cycling AloneActive Control1 Intervention
Cycling alone, with no virtual reality.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Kessler Foundation

Lead Sponsor

Trials
190
Recruited
11,300+

Consortium of Multiple Sclerosis Centers

Collaborator

Trials
9
Recruited
50,200+

Findings from Research

A study involving 68 people with multiple sclerosis showed that exergaming (EXE), balance training (BAL), and cycling (CYC) significantly improved clinical and motor symptoms, with EXE being particularly effective in enhancing gait and balance.
Exergaming also led to improvements in quality of life and walking capacity, indicating it may be a superior exercise option for reducing mobility limitations in individuals with multiple sclerosis compared to other therapies.
Exercise Effects on Multiple Sclerosis Quality of Life and Clinical-Motor Symptoms.Tollár, J., Nagy, F., Tóth, BE., et al.[2021]
A systematic review of 10 randomized clinical trials found that both conventional exercise and virtual reality (VR) exergaming positively impact the physical and cognitive abilities of people with multiple sclerosis (PwMS).
VR exergaming was generally more effective than conventional exercise in enhancing physical and cognitive abilities, improving psychosocial status, and reducing fatigue in PwMS.
Comparing virtual reality exergaming with conventional exercise in rehabilitation of people with multiple sclerosis: A systematic review.Moeinzadeh, AM., Calder, A., Petersen, C., et al.[2023]
Immersive virtual reality (VR) training using a head-mounted display (HMD) significantly improved walking speed in patients with multiple sclerosis and stroke compared to conventional treadmill training and semi-immersive VR, indicating its potential effectiveness for gait rehabilitation.
Participants reported higher motivation and preference for the HMD-based training, with no adverse effects like simulator sickness, suggesting that immersive VR could enhance therapy outcomes and patient engagement in rehabilitation programs.
Immersive virtual reality during gait rehabilitation increases walking speed and motivation: a usability evaluation with healthy participants and patients with multiple sclerosis and stroke.Winter, C., Kern, F., Gall, D., et al.[2021]

References

Exercise Effects on Multiple Sclerosis Quality of Life and Clinical-Motor Symptoms. [2021]
Comparing virtual reality exergaming with conventional exercise in rehabilitation of people with multiple sclerosis: A systematic review. [2023]
Immersive virtual reality during gait rehabilitation increases walking speed and motivation: a usability evaluation with healthy participants and patients with multiple sclerosis and stroke. [2021]
An Immersive Virtual Kitchen Training System for People with Multiple Sclerosis: A Development and Validation Study. [2023]
Effectiveness of virtual reality training for balance and gait rehabilitation in people with multiple sclerosis: a systematic review and meta-analysis. [2019]
Impact of a 5-day expedition to machu picchu on persons with multiple sclerosis. [2021]
Free-Living Peak Cadence in Multiple Sclerosis: A New Measure of Real-World Walking? [2023]
Reactivity in baseline accelerometer data from a physical activity behavioral intervention. [2018]
Lessons learned from clinical trials of exercise and physical activity in people with MS - guidance for improving the quality of future research. [2022]
10.United Statespubmed.ncbi.nlm.nih.gov
Reliability of RT3 accelerometer for measuring mobility in people with multiple sclerosis: pilot study. [2022]
Effects of a virtual reality and treadmill training on gait of subjects with multiple sclerosis: a pilot study. [2022]
An innovative training program based on virtual reality and treadmill: effects on gait of persons with multiple sclerosis. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security